Molecular evidence that exercise training has beneficial effects on cardiac performance
Commentary

Molecular evidence that exercise training has beneficial effects on cardiac performance

Marek Kiliszek1, Urszula Mackiewicz2, Michal Maczewski2, Beata Burzynska3

1Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland; 2Department of Clinical Physiology, Medical Centre of Postgraduate Education, Warsaw, Poland; 3Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland

Correspondence to: Beata Burzynska. Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5A, 02-106 Warsaw, Poland. Email: atka@ibb.waw.pl.

Submitted May 12, 2016. Accepted for publication May 18, 2016.

doi: 10.21037/atm.2016.05.53


Numerous epidemiological and observational studies demonstrate that there is an inverse relationship between physical activity and risk of cardiovascular disease (1). Recently a few randomized controlled trials revealed that exercise training is not only effective as primary prevention, but also in the secondary prevention and thus can be viewed as a “medication” that should be taken on a regular basis by a patient with cardiovascular disease. Exercise in Left Ventricular Dysfunction (ELVD) trial in a small group of 77 patients with <40% ejection fraction after a first Q-wave myocardial infarction showed that a 6-month exercise training program prevented deleterious LV remodeling (2). The Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) trial, enrolling 2,331 outpatients with stable systolic heart failure demonstrated that exercise training was associated with an 11% reduction in combined all-cause death or hospitalization (P=0.03) (3). A meta-analysis of exercise training trials in patients with chronic heart failure, majority of whom had a history of myocardial infarction, revealed that exercise training significantly reduced deaths and hospital admissions (4). Thus exercise training is recommended as part of a comprehensive approach to the patient with stable chronic heart failure (1).

Presumable mechanisms of this beneficial effect of exercise in the post-myocardial infarction and chronic heart failure setting include: improvement of VO2max, reduction of neurohormonal imbalance, antiarrhythmic effects, resolution of ventilatory abnormalities, improvement of endothelial function, improved both systolic and diastolic myocardial performance through improvement of cardiomyocyte contraction-relaxation cycle.

Cardiomyocyte contractile function has been shown to be impaired in post-MI heart failure. Decreased amplitude of myocyte contraction as well as slower kinetics of contraction-relaxation cycle has been demonstrated in many experimental models of post-MI heart failure and in humans (5,6). Cardiomyocyte contractile function is strictly controlled by beat-to-beat transient increase of intracellular Ca2+ concentration (i.e., calcium transient). After electrical activation, rising of the membrane potential opens the voltage-gated sarcolemmal L-type Ca2+ channels. This results in influx of small amount of Ca2+ to the myocyte, which activates the calcium-dependent sarcoplasmic reticulum (SR) Ca2+ release channels [ryanodine receptors (RyRs)]. This process is commonly called calcium-induced calcium release. Rapid release of considerable amount of SR Ca2+ results in increase of intracellular Ca2+ concentration and promotes Ca2+ binding to troponin C, a contractile apparatus regulatory protein. The change of tropnin C conformation upon Ca2+ binding enables actin-myosin interaction and thus myocyte contraction. Relaxation is initiated by termination of the Ca2+ release from the SR and by rapid Ca2+ removal from the cytosol. Two main transporting proteins are involved in this process: SR Ca2+-ATP-ase (SERCA) which uses ATP to pump calcium back into the SR and the Na+/Ca2+ exchanger (NCX) which transports 1 Ca2+ ion out of the cell and 3 Na+ ions into the cell. SERCA accounts for approximately 80% of removal of systolic calcium in humans and even more (about 90%) in rodents Thus, the transporting function of SERCA is the main determinant of the rate of cardiomyocyte relaxation. Additionally the SERCA transporting ability determinates the SR Ca2+ content and thus amplitude of Ca2+ transient and amplitude of myocyte contraction. The transporting function of SERCA depends on its expression, intrinsic activity of enzyme (ability to utilize ATP) and the phosphorylation level of phospholamban, endogenous SERCA inhibitor. Phospholamban is phosphorylated at Ser-16 and Thr-17 by adrenergic stimulation dependent kinase (PKA) and calmodulin and Ca2+ dependent kinase (CAMKII), respectively and increase of phosphorylation level relives SERCA inhibition (7).

In post-MI heart failure detrimental changes in Ca2+ handling have been described. Decreased SERCA transporting function has been demonstrated consistently, due to both decreases of SERCA expression as well as decreased transporting ability, mainly due to reduced level of phospholamban phosphorylation. Moreover, in many animal models and in humans increased NCX expression or/and function has also been described. These changes are additionally accompanied by an increased Ca2+ sensitivity of RyRs due to their hyperphosphorylation which results in Ca2+-leak from the SR independently from Ca2+ influx through the L-type Ca2+ channels (diastolic Ca2+-leak) (8,9).

Decreased SERCA expression accompanied by increased NCX function results in increased proportion of intracellular Ca2+ removed from the cytoplasm by NCX as compared with SERCA. This together with increased Ca2+-leak results in decreased Ca2+ SR content, amplitude of Ca2+ transient and myocyte shortening as well as the decreased rate of Ca2+ transient decay and slower relaxation. Moreover, increased NCX contribution to the relaxation increased inward current (1 Ca2+ ion is exchanged with 3 Na+ ions) and may promote afterdepolarization, premature beets and increased susceptibility to ventricular arrhythmias. Indeed the post-MI animals as well as patients with ischemic heart failure die from progressive pump failure or sudden arrhythmic events (10).

Many elegant papers have shown that regular, intensive aerobic exercise training influences Ca2+ handling and thus myocyte contraction and relaxation process in cardiomyocytes from both healthy and post-MI hearts (11).

In healthy animals exercise training resulted in approximately 30% increase of transporting activity of SERCA measured in the intact SR membranes or permeabilized cardiomyocytes (12). It was due to increased SERCA expression at mRNA and protein level as well as increased phospholamban phosphorylation. Additionally in some studies increased level of NCX and increased sensitivity of contractile apparatus were observed. Consequently, amplitude of the cell shortening and the rate of relaxation were increased (13).

In post-MI heart failure, exercise training seems to be especially beneficial. The restoration of the normal amplitude and rates of contraction and relaxation has been observed. It was associated with normalization of the expression of SERCA and NCX proteins. It supports the cardiomyocyte function and decrease propensity to Ca2+-dependent ventricular arrhythmias (14). There is growing body of evidence indicating that exercise training is able to restore of the proper expression of the protein involved in Ca2+ handling in filing hearts the mechanisms of this restoration is still poorly understood.

The discovery of microRNAs (miRNAs), abundant single-stranded small (roughly 22 nucleotide long) nonprotein-coding RNAs, has made important contribution to the better understanding of mechanisms that regulate of gene expression. MicroRNAs have been shown to be involved in most biological processes, both physiological and pathophysiological, including cardiovascular diseases. MicroRNAs are transcribed as individual or in clusters, often as part of longer transcripts, and are expressed in a tissue and cell-specific manner. The miRNA system is generally regarded as a negative regulator of specific mRNA targets. They can inhibit translation and/or promote mRNA degradation by sequence-specific base pairing (15).

Many well documented studies revealed that microRNAs were frequently downregulated in various types of cardiac diseases, including pathogenesis of MI (16). Because miRNAs are important in many cardiac pathologies, they may play a functional role in exercise-induced cardiac phenotypes.

Melo et al. in their work titled “Exercise training restores the cardiac microRNA-1 and -214 levels regulating Ca2+ handling after myocardial infarction”, published in BMC Cardiovascular Disorders (17) demonstrated that myocardial infarction in the rat resulted in reduced expression of SERCA and increased expression of NCX. Expression of microRNA-214 that targets SERCA, was increased, white that of microRNA-1 that targets NCX, was reduced. Ten weeks of exercise training resulted in restoration of both microRNA levels and prevents changes of expression of both calcium transporters induced by myocardial infarction. These results suggest that changes in microRNA are responsible for restoration of SERCA and NCX expression, through this conclusion is only based on the above mentioned correlations.

This article provides new data on possible mechanisms behind effects of exercise training on cardiac performance in infracted heart. microRNA-1 is cardiac specific miRNA and plays a role in heart hypertrophy, myocardial infarction, and arrhythmias, by promoting apoptosis. Recently, studies have revealed that miR-1 was frequently downregulated in various types of cardiac disease but when overexpressed, played a protective role against cardiac hypertrophy or heart failure by regulating several hypertrophy-associated genes, including transcription factors, receptor ligands, apoptosis regulators and ion channels (18). Overexpression of microRNA-1 and other miRs is implicated in regulation of G-PCR and calcium handling (19). Second miRNA investigated by authors, microRNA-214, improved LV remodeling and decreased apoptosis of myocardial cell and had a protective effect on heart function (20).

In summary, the study by Melo et al. highlights new potential mechanisms of beneficial effects of exercise on the post-MI heart, providing new areas for future research.


Acknowledgements

Funding: Research on role of mRNAs and miRNAs in heart failure conducted in our Lab is supported by The National Centre for Research and Development, Poland (TANGO1/266456/NCBR/2015).


Footnote

Provenance: This is a Guest Commentary commissioned by Section Editor Zhijun Han, MD (Department of Laboratory Medicine, Wuxi Second Hospital, Nanjing Medical University, Wuxi, China).

Conflict of Interest: The authors have no conflict of interest to declare.

Comment on: Melo SF, Barauna VG, Neves VJ, et al. Exercise training restores the cardiac microRNA-1 and -214 levels regulating Ca2+ handling after myocardial infarction. BMC Cardiovasc Disord 2015;15:166.


References

  1. Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013;128:873-934. [Crossref] [PubMed]
  2. Giannuzzi P, Temporelli PL, Corrà U, et al. Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial. Circulation 1997;96:1790-7. [Crossref] [PubMed]
  3. O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301:1439-50. [Crossref] [PubMed]
  4. Piepoli MF, Davos C, Francis DP, et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004;328:189. [Crossref] [PubMed]
  5. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol 2002;34:951-69. [Crossref] [PubMed]
  6. Yano M, Ikeda Y, Matsuzaki M. Altered intracellular Ca2+ handling in heart failure. J Clin Invest 2005;115:556-64. [Crossref] [PubMed]
  7. Leszek P, Szperl M, Klisiewicz A, et al. Alteration of myocardial sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger expression in human left ventricular volume overload. Eur J Heart Fail 2007;9:579-86. [Crossref] [PubMed]
  8. Marx SO, Marks AR. Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases. J Mol Cell Cardiol 2013;58:225-31. [Crossref] [PubMed]
  9. Mackiewicz U, Maczewski M, Konior A, et al. Sarcolemmal Ca2+-ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the rat. Cardiovasc Res 2009;81:546-54. [Crossref] [PubMed]
  10. Myles RC, Burton FL, Cobbe SM, et al. The link between repolarisation alternans and ventricular arrhythmia: does the cellular phenomenon extend to the clinical problem? J Mol Cell Cardiol 2008;45:1-10. [Crossref] [PubMed]
  11. Kemi OJ, Wisløff U. Mechanisms of exercise-induced improvements in the contractile apparatus of the mammalian myocardium. Acta Physiol (Oxf) 2010;199:425-39. [Crossref] [PubMed]
  12. Kemi OJ, Ceci M, Condorelli G, et al. Myocardial sarcoplasmic reticulum Ca2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil 2008;15:145-8. [Crossref] [PubMed]
  13. Wisløff U, Loennechen JP, Currie S, et al. Aerobic exercise reduces cardiomyocyte hypertrophy and increases contractility, Ca2+ sensitivity and SERCA-2 in rat after myocardial infarction. Cardiovasc Res 2002;54:162-74. [Crossref] [PubMed]
  14. Venetucci LA, Trafford AW, O'Neill SC, et al. The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc Res 2008;77:285-92. [Crossref] [PubMed]
  15. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469:336-42. [Crossref] [PubMed]
  16. Chistiakov DA, Orekhov AN, Bobryshev YV. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol 2016;94:107-21. [Crossref] [PubMed]
  17. Melo SF, Barauna VG, Neves VJ, et al. Exercise training restores the cardiac microRNA-1 and -214 levels regulating Ca2+ handling after myocardial infarction. BMC Cardiovasc Disord 2015;15:166. [Crossref] [PubMed]
  18. Sygitowicz G, Tomaniak M, Błaszczyk O, et al. Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results. Arch Cardiovasc Dis 2015;108:634-42. [Crossref] [PubMed]
  19. Yang X, Qin Y, Shao S, et al. MicroRNA-214 Inhibits Left Ventricular Remodeling in an Acute Myocardial Infarction Rat Model by Suppressing Cellular Apoptosis via the Phosphatase and Tensin Homolog (PTEN). Int Heart J 2016;57:247-50. [Crossref] [PubMed]
  20. Fernandes T, Baraúna VG, Negrão CE, et al. Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs. Am J Physiol Heart Circ Physiol 2015;309:H543-52. [Crossref] [PubMed]
Cite this article as: Kiliszek M, Mackiewicz U, Maczewski M, Burzynska B. Molecular evidence that exercise training has beneficial effects on cardiac performance. Ann Transl Med 2016;4(11):228. doi: 10.21037/atm.2016.05.53

Download Citation